Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
This HIV Drug Is Making a Difference. Now Republicans Want to Make It Unaffordable

Republican's plan to replace the ACA would complicate PrEP access, particularly for low-income Americans in the 31 states, plus the District of Columbia, that adopted the Medicaid expansion.

Published
09 March 2017
From
Money
Georgia HIV infections drop 6 percent annually for 6 years

HIV infections in Georgia dropped 6% each year from 2008 to 2014. According to a recent analysis by the Centers for Disease Control and Prevention (CDC), Georgia is among eight states whose infection rate dropped significantly during the six-year period.

Published
08 March 2017
From
WTVC
Clinical Commissioning Policy: Tenofovir Alafenamide for treatment of HIV 1 in adults and adolescents

TAF containing products can be made available to patients who have defined renal or bone problems or who have medical reasons why they cannot take other HIV drugs.

Published
06 March 2017
From
NHS England
Regulator defends hepatitis charity criticised on BBC show

The Charity Commission has defended a health charity that attempted to force the NHS to buy more of a treatment for hepatitis C, having accepted funding from the US company that makes it.

Published
02 March 2017
From
Third Sector
TB partners, patients ask: How does a bacterium responsible for nearly a third of drug-resistance deaths not make list of R&D priority pathogens?

While the unveiling of a list highlighting the need to fund drug development against specific pathogens represented just a beginning for some antimicrobial resistance fighting efforts, the list represented a setback for TB drug development, advocates say.

Published
02 March 2017
From
Science Speaks
An excellent graphical history of drug treatment in the UK

Lifeline recently published an excellent infographic crammed with information on the way drug and alcohol treatment services have been funded over the last 30 years. It contains information on how the various cultural and political shifts over that time have altered the expectations on these services.

Published
02 March 2017
From
Russell Webster (blog)
'I bought hepatitis C cure from Bangladesh'

Zoe Sharam bought a hepatitis C cure, deemed too expensive for her by the NHS, online from Bangladesh. She speaks to the BBC's Victoria Derbyshire programme.

Published
02 March 2017
From
BBC Health
Hepatitis C drugs re-energize global fight over patents

The liver disease hepatitis C is the new battleground for lawsuits intended to slash the cost of life-saving medicines. In February alone, five suits were filed in India and Argentina claiming that the latest class of antiviral drugs does not warrant the 20-year patent monopoly that manufacturers have sought in those countries.

Published
01 March 2017
From
Nature
After fracas, Global Fund abandons plan to pick new chief and reopens search

Leaks. Concerns about alienating President Donald Trump. Allegations about conflicts of interest. All of those reasons factored in to a surprise decision today by the board of the Global Fund to Fight AIDS, Tuberculosis and Malaria to restart its search for a new executive director.

Published
28 February 2017
From
Science
The Medicines Patents Pool Publishes 2017 Prioritization Report Targeting New HIV and Hepatitis C Medicines for In-licensing

The Medicines Patent Pool released its 2017 prioritization report today selecting five HIV and two hepatitis C compounds for potential licensing agreements. The annual medicines priority report, traditionally reviewing MPP’s target list for HIV, this year expands to important treatments for the hepatitis C virus (HCV).

Published
28 February 2017
From
Medicines Patent Pool

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.